The IQVIA Institute for Human Data Science
IQVIA Institute Research Highlights
The IQVIA Institute for Human Data Science spent the past year addressing major health system issues and contributing to a deeper understanding of the challenges and opportunities that impact the transformation of healthcare. The Institute researched and published 16 reports, hosted 11 public webinars, convened 6 multi-stakeholder roundtables, and participated in more than 50 external forums, helping to drive and inform important conversations on the future of healthcare.
COVID-19 Resources and Insights
The COVID-19 pandemic is having a deep and lasting impact on healthcare systems around the world. At the IQVIA Institute we are using Human Data Science to develop a unique, evidence-based perspective on how the health system is reacting, and adapting. Explore resources and insights.
The Use of Medicines in the U.S. 2022
This annual trend report is intended to provide a grounding in relevant information across a range of issues with both short- and long-term implications, including trends in the use and spending on medicines in the U.S., spending and growth drivers, patient out-of-pocket costs, and future outlook on these topics.
The trajectory of biosimilars has changed – and according to current projections, will continue on an upward path. With continued increases in biologics spending expected, the biosimilars market presents an opportunity for savings on medicines.
IQVIA Institute leadership and a panel of experts from healthcare and the nonprofit sector discuss ongoing issues around biosimilars. This webinar follows the release of a report on the same topic, which takes a close look at the current state of the biologics market in the United States.
Advancing Human Data Science
The IQVIA Institute for Human Data Science delivers objective, relevant insights and research that accelerates our understanding of how health systems function, how treatment is evolving, and how care is being delivered. These insights are critical to sound decision making, and ultimately to improved human health outcomes.
With access to IQVIA's institutional knowledge, advanced analytics, technology and unparalelled data, the Institute works in tandem with a broad set of stakeholders, including government agencies, academic institutions, the life sciences industry, and payers.
Find where Murray Aitken and Michael Kleinrock will be speaking next.
See press releases and news coverage about the IQVIA Institute.
Murray Aitken is the executive director of the IQVIA Institute for Human Data Science.
Michael Kleinrock serves as research director for the IQVIA Institute for Human Data Science.